Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Massi

Showing results (321-330 of 357) with videos related to

Pageof 36
Sort By:
Journal of Translational Medicine|November 9, 2017
Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 casesMaria A Pizzichetta, Daniela Massi, Mario Mandalà, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2020
Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)Mario Mandalà, Francesca Galli, Roberto Patuzzo, et al.
Critical Reviews in Oncology/Hematology|October 10, 2020
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patientsUmberto Malapelle, Giulio Rossi, Pasquale Pisapia, et al.
European Journal of Cancer (Oxford, England : 1990)|September 27, 2020
Corrigendum to "Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicenter study of the Italian Melanoma Intergroup (IMI)" [Eur J Canc 137 (2020). Pages 30-39]Mario Mandalà, Francesca Galli, Roberto Patuzzo, et al.
Head & Neck|June 17, 2014
Lymphatic and blood vasculature in primary cutaneous melanomas of the scalp and neckSandro Pasquali, Maria Cristina Montesco, Chiara Ginanneschi, et al.
Virchows Archiv : an International Journal of Pathology|January 28, 2026
Toward a regional digital pathology network in Tuscany: current status and implementation roadmapGiuseppe Nicolò Fanelli, Filippo Ugolini, Alessandro Ginori, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 19, 2023
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitorsMario Mandalà, Giuseppe Palmieri, Vienna Ludovini, et al.
Histopathology|April 15, 2025
Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck regionCostantino Ricci, Maria Vittoria Altavilla, Dario de Biase, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 12, 2018
MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortiumAlexander J Stratigos, Maria Concetta Fargnoli, Arcangela De Nicolo, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 14, 2026
Bi-directional regulation between NAD/NAMPT and IFN-γ/PD-L1 axes via BRD4/IRF1 and mitochondrial respiration in metastatic cutaneous melanomaIrene Fiorilla, Beatrice Ghezzi, Alessia Ponzano, et al.
Pageof 36

Showing results (321-330 of 357) with videos related to

Sort By:
Pageof 36
Journal of Translational Medicine|November 9, 2017
Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 casesMaria A Pizzichetta, Daniela Massi, Mario Mandalà, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2020
Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)Mario Mandalà, Francesca Galli, Roberto Patuzzo, et al.
Critical Reviews in Oncology/Hematology|October 10, 2020
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patientsUmberto Malapelle, Giulio Rossi, Pasquale Pisapia, et al.
European Journal of Cancer (Oxford, England : 1990)|September 27, 2020
Corrigendum to "Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicenter study of the Italian Melanoma Intergroup (IMI)" [Eur J Canc 137 (2020). Pages 30-39]Mario Mandalà, Francesca Galli, Roberto Patuzzo, et al.
Head & Neck|June 17, 2014
Lymphatic and blood vasculature in primary cutaneous melanomas of the scalp and neckSandro Pasquali, Maria Cristina Montesco, Chiara Ginanneschi, et al.
Virchows Archiv : an International Journal of Pathology|January 28, 2026
Toward a regional digital pathology network in Tuscany: current status and implementation roadmapGiuseppe Nicolò Fanelli, Filippo Ugolini, Alessandro Ginori, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 19, 2023
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitorsMario Mandalà, Giuseppe Palmieri, Vienna Ludovini, et al.
Histopathology|April 15, 2025
Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck regionCostantino Ricci, Maria Vittoria Altavilla, Dario de Biase, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 12, 2018
MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortiumAlexander J Stratigos, Maria Concetta Fargnoli, Arcangela De Nicolo, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 14, 2026
Bi-directional regulation between NAD/NAMPT and IFN-γ/PD-L1 axes via BRD4/IRF1 and mitochondrial respiration in metastatic cutaneous melanomaIrene Fiorilla, Beatrice Ghezzi, Alessia Ponzano, et al.
Pageof 36